People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Other Health Care, Biotechnology, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Airxpanders Inc | — | Other Health Care | Series A | $60.0M | $300.5M | 2010 |
| Viveve Medical, Inc. | — | Biotechnology | Series A | $41.5M | $12.3M | 2015 |
| Humanigen, Inc | — | Pharmaceuticals | Series B | $39.2M | $16.8M | 2012 |
| Euthymics Bioscience, Inc. | — | Biotechnology | Series B | $31.3M | $11.9M | 2017 |
| Viveve, Inc. | — | Other | Seed | $5.5M | $74.4M | 2009 |
Brigitte Smith at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brigitte Smith on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Simpson | 2 | 4 |
| Andrew Schwab | 1 | 16 |
| Campbell Murray | 1 | 9 |
| Albert Cha | 1 | 9 |
| Michael Harrison | 1 | 8 |
| James Healy | 1 | 8 |
| Timothy J. Barberich | 1 | 7 |
| Timothy Barberich | 1 | 6 |
| Douglas A. Branch | 1 | 5 |
| Arlene Morris | 1 | 5 |
| Tadmor Shalon | 1 | 5 |
| Cameron Durrant | 1 | 5 |
| Paul Weiss | 1 | 5 |
| Chris Jones | 1 | 5 |
| Dennis Condon | 1 | 5 |
| DENNIS HENNER | 1 | 5 |
| Daniel Omstead | 1 | 4 |
| Brian Clevinger | 1 | 4 |
| Campbell A. Murray | 1 | 4 |
| Daniel Janney | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.